Saxne T, Månsson B, Heinegård D: Biomarkers for Cartilage and Bone in Rheumatoid Arthritis. 2006, Oxford: Oxford University Press, 2
Google Scholar
Hesselstrand R, Kassner A, Heinegård D, Saxne T: COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker. Ann Rheum Dis. 2008, 67: 1242-8.
Article
CAS
PubMed
Google Scholar
Oldberg A, Antonsson P, Lindblom K, Heinegård D: COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 1992, 267: 22346-50.
CAS
PubMed
Google Scholar
Rosenberg K, Olsson H, Mörgelin M, Heinegård D: Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem. 1998, 273: 20397-403. 10.1074/jbc.273.32.20397.
Article
CAS
PubMed
Google Scholar
Halasz K, Kassner A, Mörgelin M, Heinegård D: COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem. 2007, 282: 31166-73. 10.1074/jbc.M705735200.
Article
CAS
PubMed
Google Scholar
Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R: Interactions between the cartilage oligomeric matrix protein and matrilins: implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem. 2004, 279: 25294-8. 10.1074/jbc.M403778200.
Article
CAS
PubMed
Google Scholar
Happonen KE, Saxne T, Aspberg A, Mörgelin M, Heinegård D, Blom AM: Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum. 2010, 62: 3574-83. 10.1002/art.27720.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M: Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol. 2004, 34: 1208-16. 10.1002/eji.200424895.
Article
CAS
PubMed
Google Scholar
Nandakumar KS, Jansson A, Xu B, Rydell N, Blom AM, Holmdahl R: A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis. PloS One. 2010, 5: e13511-10.1371/journal.pone.0013511.
Article
PubMed Central
PubMed
Google Scholar
Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE: Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum. 2006, 54: 1143-50. 10.1002/art.21729.
Article
CAS
PubMed
Google Scholar
Morgan BP, Daniels RH, Williams BD: Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol. 1988, 73: 473-8.
PubMed Central
CAS
PubMed
Google Scholar
Jose PJ, Moss IK, Maini RN, Williams TJ: Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis. 1990, 49: 747-52. 10.1136/ard.49.10.747.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tanimoto K, Cooper NR, Johnson JS, Vaughan JH: Complement fixation by rheumatoid factor. J Clin Invest. 1975, 55: 437-45. 10.1172/JCI107949.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sato Y, Sato R, Watanabe H, Kogure A, Watanabe K, Nishimaki T, Kasukawa R, Kuraya M, Fujita T: Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors. Ann Rheum Dis. 1993, 52: 795-800. 10.1136/ard.52.11.795.
Article
PubMed Central
CAS
PubMed
Google Scholar
Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, Huizinga TW, Toes RE: Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009, 60: 1923-31. 10.1002/art.24622.
Article
CAS
PubMed
Google Scholar
Sjöberg A, Önnerfjord P, Mörgelin M, Heinegård D, Blom AM: The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005, 280: 32301-8. 10.1074/jbc.M504828200.
Article
PubMed
Google Scholar
Sjöberg AP, Manderson GA, Mörgelin M, Day AJ, Heinegård D, Blom AM: Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2009, 46: 830-9. 10.1016/j.molimm.2008.09.018.
Article
PubMed Central
PubMed
Google Scholar
Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ, Gingras AR, Mantovani A, Hack EC, Roos A: Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol. 2002, 32: 1726-36. 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R.
Article
CAS
PubMed
Google Scholar
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-24. 10.1002/art.1780310302.
Article
CAS
PubMed
Google Scholar
Andersson ML, Thorstensson CA, Roos EM, Petersson IF, Heinegård D, Saxne T: Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskeletal Disord. 2006, 7: 98-10.1186/1471-2474-7-98.
Article
Google Scholar
Masi AT, Rodnan GP, Medsger TA, Altman RD: Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980, 25: 581-90.
Article
Google Scholar
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15: 202-5.
CAS
PubMed
Google Scholar
Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D, Wigley F, Medsger TA, Steen V, Moreland L, Dixon M, Massa M, Lally E, McCloskey D, Varga J, Ingenito F, Furst D: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995, 22: 1281-5.
CAS
PubMed
Google Scholar
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-7. 10.1002/art.1780251101.
Article
CAS
PubMed
Google Scholar
Gladman DD, Ibanez D, Urowitz MB: Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002, 29: 288-91.
PubMed
Google Scholar
Crnkic M, Månsson B, Larsson L, Geborek P, Heinegård D, Saxne T: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther. 2003, 5: R181-5. 10.1186/ar760.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001, 44: 1237-47. 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F.
Article
CAS
PubMed
Google Scholar
Saxne T, Lindell M, Månsson B, Petersson IF, Heinegård D: Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology (Oxford, England). 2003, 42: 903-4. 10.1093/rheumatology/keg186.
Article
CAS
Google Scholar